In another biopsy-proven cohort of 538 Caucasians patients with NAFLD, lean NAFLD subjects had higher total bile acid and FGF19 levels compared to those with non-lean NAFLD and also showed decreased levels of butyric acid [74]. Here, FGF19 is linked to metabolic dysfunction-associated steatotic liver disease.